CROI 2015 Program and Abstracts

Poster Listings

WEDNESDAY, FEBRUARY 25, 2015 Session P-P5 Poster Session

739 Impact of Antiretroviral Drugs on Hypertension in HIV-Positive Persons: D:A:D Study Camilla I. Hatleberg 1 ; Lene Ryom 1 ; Antonella d’Arminio Monforte 2 ; Eric Fontas 3 ; Peter Reiss 4 ; Ole Kirk 1 ;Wafaa M. El-Sadr 5 ; Stéphane DeWit 6 ; Jens D. Lundgren 1 ; Caroline Sabin 7 On behalf of the D:A:D Study group 1 Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 2 San Paolo University Hospital, Milan, Italy; 3 Nice University Hospital, Nice, France; 4 Academic Medical Center, University of Amsterdam, Amstredam, Netherlands; 5 Columbia University, New York, NY, US; 6 Centre Hospitalier Universitaire St. Pierre Hospital, Brussels, Belgium; 7 University College London, London, United Kingdom 740 Population-Based Assessment of Hypertension Among HIV Patients in Rural Uganda Dalsone Kwarisiima 1 ; Prashant Kotwani 3 ; Norton Sang 4 ; Florence Mwangwa 2 ;Vivek Jain 3 ; Dathan Byonanebye 2 ; James Ayieko 4 ; Laura Balzer 5 ; Diane Havlir 3 ; Moses R. Kamya 6 1 Makerere University Joint AIDS Program, Kampala, Uganda; 2 Infectious Disease Research Collaboration, Kampala, Uganda; 3 University of California San Francisco, San Francisco, CA, US; 4 Research Care Training Program, Kenya Medical Research Institute, Nairobi, Kenya; 5 University of Berkeley, Berkeley, CA, US; 6 Makerere University College of Health Sciences, Kampala, Uganda 2:30 pm– 4:00 pm What Predicts Risk for CVD in HIV? 741 CD4/CD8 Ratio, Age, and Serious Noninfectious Outcomes in HIV-Infected Adults Jessica L. Castilho ; MeganTurner; Sally Bebawy; Bryan E. Shepherd;Timothy Sterling Vanderbilt University School of Medicine, Nashville, TN, US 742 Relationship Between Confirmed eGFR and Cardiovascular Disease in HIV-Positive Persons Lene Ryom 1 ; Jens D. Lundgren 1 ; Peter Reiss 2 ; Michael Ross 3 ; Christoph Fux 4 ; Philippe Morlat 7 ; Olivier Moranne 5 ; Colette Smith 6 ; Caroline Sabin 6 ; Amanda Mocroft 6 On Behalf of the D:A:D Study Group 1 CHIP, Department of Infectious Diseases and Rheumatology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark; 2 Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; 3 Division of Nephrology, Mount Sinai School of Medicine, New York, New York City, NY, US; 4 Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland; 5 Nephrology department, Public Health department, CHU Nice, Nice, France; 6 University College London, London, United Kingdom; 7 University of Bordeaux, INSERM U 897, CHU de Bordeaux, Bordeaux, France 743 Smoking, Other Substance Use and Coronary Atherosclerosis Among HIV-Infected and Uninfected Men Sean G. Kelly 1 ; Michael Plankey 3 ;Wendy Post 2 ; Xiuhong Li 2 ; Ron Stall 4 ; Lisa P. Jacobson 2 ; MalloryWitt 5 ; Lawrence Kingsley 4 ; Christopher Cox 2 ; Frank J. Palella 1 1 Northwestern University, Chicago, IL, US; 2 Johns Hopkins University School of Medicine, Baltimore, MD, US; 3 Georgetown University, Washington, DC, US; 4 University of Pittsburgh, Pittsburgh, PA, US; 5 University of California Los Angeles, Los Angeles, CA, US 744 Pericardial Fat Density: A Novel Marker of Cardiometabolic Risk in HIV Infection Chris T. Longenecker ; Mark Schlucter;Yiying Liu; Grace A. McComsey Case Western Reserve University, Cleveland, OH, US 745 The Effect of Physical Activity on Cardiometabolic Health and Inflammation in HIV Sahera Dirajlal-Fargo 1 ; Allison R.Webel 2 ; Bruce Kinley 3 ; Danielle Labbato 3 ;Ying Jiang 4 ; Sara M. Debanne 4 ; Grace A. McComsey 1 1 Rainbow Babies and Children’s Hospital, Case Western Reserve University School of Medicine, Cleveland, OH, US; 2 Frances Payne Bolton School of Nursing Case Western Reserve University, Cleveland, OH, US; 3 University Hospitals Case Medical Center, Cleveland, OH, US; 4 Case Western Reserve University, Cleveland, OH, US TUESDAY, FEBRUARY 24, 2015 Session P-P4 Poster Session Poster Hall

Poster Hall

2:30 pm– 4:00 pm Cardiovascular Risk Prediction 746 Cumulative HIV Care Measures Highly AssociatedWith Acute Myocardial Infarction Jorge L. Salinas 1 ; ChristopherT. Rentsch 2 ;Vincent C. Marconi 1 ; JanetTate 3 ; Adeel A. Butt 4 ; Matthew S. Freiberg 4 ; Matthew B. Goetz 5 ; Maria Rodriguez-Barradas 6 ; Amy Justice 3 ; David Rimland 1 1 Emory University, Atlanta, GA, US; 2 Atlanta VA Hospital, Decatur, GA, US; 3 Yale University, New Haven, CT, US; 4 University of Pittsburgh, Pittsburgh, PA, US; 5 David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, US; 6 Baylor College of Medicine, Houston, TX, US 747 Cardiovascular Disease Risk Prediction in the HIV Outpatient Study (HOPS) Angela M.Thompson-Paul 1 ; Kenneth A. Lichtenstein 2 ; Carl Armon 3 ; Kate Buchacz 1 ; Rachel Debes 3 ; Joan S. Chmiel 4 ; Frank J. Palella 4 ; Stanley C.Wei 1 ; Jacek Skarbinski 1 ; JohnT. Brooks 1 1 US Centers for Disease Control and Prevention, Atlanta, GA, US; 2 National Jewish Health, Denver, CO, US; 3 Cerner Corporation, Vienna, VA, US; 4 Northwestern University, Feinberg School of Medicine, Chicago, IL, US 748 Incidence and Risk of Myocardial Infarction (MI) by Type in the NA- ACCORD Daniel R. Drozd 1 ; Mari M. Kitahata 1 ; Keri N. Althoff 2 ; Jinbing Zhang 2 ; Susan R. Heckbert 1 ; Matthew J. Budoff 3 ; Frank J. Palella 4 ; Daniel B. Klein 5 ; Richard D. Moore 6 ; Heidi M. Crane 1 1 University of Washington, Seattle, WA, US; 2 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US; 3 University of California Los Angeles, Los Angeles, CA, US; 4 Northwestern University, Chicago, IL, US; 5 Kaiser Permanente Northern California, Hayward, CA, US; 6 Johns Hopkins University, Baltimore, MD, US 749LB Abacavir Use and Risk for Myocardial Infarction in the NA-ACCORD Frank J. Palella 1 ; Keri N. Althoff 2 ; Richard Moore 3 ; Jinbing Zhang 2 ; Mari Kitahata 4 ; Stephen J. Gange 2 ; Heidi M. Crane 4 ; Daniel R. Drozd 4 ; JohnT. Brooks 5 ; Richard Elion 6 1 Northwestern University, Feinberg School of Medicine, Chicago, IL, US; 2 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US; 3 Johns Hopkins University, Baltimore, MD, US; 4 University of Washington, Seattle, WA, US; 5 US Centers for Disease Control and Prevention, Atlanta, GA, US; 6 George Washington University, Washington, DC, US 750 HIV-Infected Veterans and the New ACC/AHA Cholesterol Guidelines: Got Statins? Meredith E. Clement 1 ; Lawrence Park 1 ; Ann Marie Navar-Boggan 1 ; Nwora L. Okeke 1 ; Michael Pencina 1 ; Pamela Douglas 1 ; Susanna Naggie 1 1 Duke University, Durham, NC, US; 2 Duke University, Durham, NC, US; 3 Duke University, Durham, NC, US 751 Evaluation of the ACC/AHA CVD Risk Prediction Algorithm Among HIV- Infected Patients Susan Regan 2 ; James B. Meigs 2 ; Joseph Massaro 3 ; Ralph B. D’Agostino 3 ; Steven Grinspoon 2 ; Virginia A. Triant 2 1 Massachusetts General Hospital, Harvard Medical School, Boston, MA, US; 2 Massachusetts General Hospital, Harvard Medical School, Boston, MA, US; 3 Boston University, Boston, MA, US; 4 Massachusetts General Hospital, Harvard Medical School, Boston, MA, US

Poster Listings

TUESDAY, FEBRUARY 24, 2015 Session P-P6 Poster Session

Poster Hall

2:30 pm– 4:00 pm Biomarkers and Atherosclerosis 752 IL-6 and CD8 Senescence Independently AssociateWith Atherosclerosis in Treated HIV Denise C. Hsu 1 ; Zonghui Hu 1 ; Courtney Carroll 2 ; Kristinalisa Maka 2 ; Adam Rupert 3 ; Steven Deeks 2 ; S. C. Kalapus 2 ; Priscilla Hsue 2 ; Irini Sereti 1 1 National Institute of Allergy and Infectious Diseases, Bethesda, MD, US; 2 University of California San Francisco, San Francisco, CA, US; 3 Leidos Biomedical Research, Inc, Frederick, MD, US

58

CROI 2015